Antengene (FRA:722) Short Interest


FRA:722 Antengene Corp Ltd FRA:722
39 GF Score
Price €0.36
GF Value €0.16
! 5 Warning Signs
View Full Analysis

What is Antengene Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:722 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Antengene's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Antengene Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Antengene's Short Interest distribution charts can be found below:

* The bar in red indicates where Antengene's Short Interest falls into.


FRA:722
39GF Score
Antengene Corp Ltd FRA:722
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Antengene (FRA:722) Overvalued in 2026?

Based on GuruFocus' analysis, Antengene stock appears to be overvalued. The current stock price of €0.36 is trading 125% above its estimated GF Value™ of €0.16.

Key valuation signals for FRA:722:

  • Short Interest:
  • GF Value™: €0.16 vs. price of €0.36 (125% above fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the FRA:722 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Antengene Business Description

Other Exchanges 06996:Hong Kong
Address 1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN
Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically, it operates in the Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.
39GF Score

Get the complete analysis for FRA:722

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.36
Price
€0.16
GF Value